Early Enteral Nutrition (via nasogastric or nasojejunal tube)
Treatment for Pancreatitis
Typical Dosage: gradually advanced, 25-50 mL/hour initial
Effectiveness
80%
Safety Score
85%
Clinical Trials
250
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
gradually advanced, 25-50 mL/hour initial
Time to Effect
days
Treatment Duration
days to weeks
Evidence Quality
HIGHNumber Needed to Treat (NNT)
7(Treat 7 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$500
Monitoring:$1,000
Side Effect Mgmt:$100
Total Annual:$1,600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$2,133.33
Comparison vs Total Parenteral Nutrition (TPN)
Cost Difference
$-5,000/year
Less expensive
QALY Difference
+0.30 QALYs
Better outcomes
Dominance
DOMINATESBetter + cheaper
Early Enteral Nutrition (via nasogastric or nasojejunal tube) Outcomes
for Pancreatitis
Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+75%
Common Side Effects
Diarrhea
+15%
Abdominal distension
+7%
Tube displacement
+7%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov